Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2005 Apr;26(4):689-92.

Perinatal exposure to antiretroviral agents: risks and benefits

Gwendolyn B Scott
Editorial

Perinatal exposure to antiretroviral agents: risks and benefits

Gwendolyn B Scott. AJNR Am J Neuroradiol. 2005 Apr.
No abstract available

PubMed Disclaimer

References

    1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type-1 with zidovudine treatment. N Eng J Med 1994;331:1173–1180 - PubMed
    1. US Centers for Disease Control. Public Health Service recommendations on use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43:1–20 - PubMed
    1. Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States, June 23, 2004 [http://AIDSinfo.nih.gov] - PubMed
    1. Stiehm ER, Lambert J, Mofenson L, et al. Efficacy of zidovudine and HIV hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group Protocol 185. J Infect Dis 1999;179:567–575 - PubMed
    1. Garcia PM, Kalish LA, Pitt J, et al. Maternal plasma HIV-1 RNA levels and risk of perinatal transmission. N Engl J Med 1999;341:394–402 - PubMed

Publication types

MeSH terms

Substances